BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11725818)

  • 1. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee JH; Lee KU; Lee DY; Youn JC; Youn JY; Woo JI
    J Neural Transm (Vienna); 2001; 108(10):1159-66. PubMed ID: 11725818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee JH; Lee DY; Lee KU; Youn JY; Woo JI
    Neurosci Lett; 2001 Jul; 308(1):45-8. PubMed ID: 11445282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
    Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
    Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
    Simão-Silva DP; Bertolucci PH; de Labio RW; Payão SL; Furtado-Alle L; Souza RL
    Chem Biol Interact; 2013 Mar; 203(1):358-60. PubMed ID: 23022600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
    Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
    Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K).
    Grubber JM; Saunders AM; Crane-Gatherum AR; Scott WK; Martin ER; Haynes CS; Conneally PM; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Neurosci Lett; 1999 Jul; 269(2):115-9. PubMed ID: 10430518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
    Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
    Wiebusch H; Poirier J; Sévigny P; Schappert K
    Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
    Kehoe PG; Williams H; Holmans P; Wilcock G; Cairns NJ; Neal J; Owen MJ
    J Med Genet; 1998 Dec; 35(12):1034-5. PubMed ID: 9863603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.
    Rondeau V; Iron A; Letenneur L; Commenges D; Duchêne F; Arveiler B; Dartigues JF
    Eur J Neurol; 2006 Sep; 13(9):1022-5. PubMed ID: 16930371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
    Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
    Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
    McIlroy SP; Crawford VL; Dynan KB; McGleenon BM; Vahidassr MD; Lawson JT; Passmore AP
    J Med Genet; 2000 Mar; 37(3):182-5. PubMed ID: 10699053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
    Lehmann DJ; Johnston C; Smith AD
    Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
    Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
    Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.